employer glp-1 coverage news Insurance - Why Employers Should Cover GLP-1s The GLP-1 Access Gap: Mapping

You might see microcrystalline cellulose (a capsule filler) or other additives, but the active playersthe probiotics and prebioticsare what provide relief

In summary, our data show that a 3-week treatment with the GLP-1 RA dulaglutide reduced fluid intake, thirst perception, and voiding frequency in patients with primary polydipsia

Symptoms of hypoglycemia include tremor, palpitations, sweating, confusion, and in severe cases, loss of consciousness or seizures

Symptoms can include severe abdominal pain, nausea and vomiting

Side effects are often dose-dependent, with higher doses of retatrutide generally resulting in a higher incidence of gastrointestinal adverse events

The initiative is set to launch in April for Medicaid and January 2027 for Medicare plans